XWEL· Health Care› Diagnostics & Research

XWELL, Inc.

Stage 4 · Declining · week 4

As of Oct 22, 2026, XWELL is in Stage 4, the downtrend phase, now in week 4 (since Sep 28, 2026). It closed at $0.68, 60.0% below its 52-week high and below its 200-day average, which is rising.

XWELL, Inc. engages in the provision of health and wellness services to travelers in the United States and internationally. More about the company

$0.68

-2.97% today

$6.8M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is XWEL early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 29w

S4 35w

S4 16w

S3 16w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S1 1w → S4 29w → S1 6w → S4 8w → S1 5w → S2 7w → S3 2w → S2 1w → S3 4w → S4 35w → S1 11w → S2 3w → S3 5w → S4 16w → S1 4w → S2 9w → S3 16w → S4 4w current

Total tracked: 165 weeks across 18 stage runs.

XWEL among Diagnostics & Research35th of 44 by relative strength

All 44 →

Stocks in Diagnostics & Research ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	CDNACareDx, Inc.	Stage 2 · wk 24	99	+27.3%
2	BDSXBiodesix, Inc.	Stage 2 · wk 18	98	−18.3%
3	ILMNIllumina, Inc.	Stage 2 · wk 24	97	+5.5%
4	GHGuardant Health, Inc.	Stage 2 · wk 21	97	−7.6%
5	NTRANatera, Inc.	Stage 2 · wk 20	96	+2.7%
6	CRLCharles River Laboratories International, Inc.	Stage 2 · wk 16	92	+22.5%
7	RVTYRevvity, Inc.	Stage 2 · wk 18	90	+10.7%
8	PSNLPersonalis, Inc.	Stage 2 · wk 17	90	−3.2%
…35	XWELXWELL, Inc.	Stage 4 · wk 4	33	−24.4%

vs 52W High

-60.0%

$0.29 lo$1.70 hi

60.0% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 4

1w13w26w

Week 4, early Stage 4 decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-31.8%

200 DMA: $1.00 · rising

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

0.94x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-24.4%

-35.2%

-40.4%

YTD

+51.1%

-30.6%

Scan Membership

Breakout Watch

Latest: 2024-09-26

5 appearances in last 60 days. First seen: 2020-06-22.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 4 · Vol 0.94x

2026-10-21S4

Wk 4 · Vol 4.09x

2026-10-20S4

Wk 4 · Vol 2.15x

2026-10-19S4

Wk 4 · Vol 1.46x

2026-10-16S4

Wk 3 · Vol 0.73x

2026-10-15S4

Wk 3 · Vol 2.24x

2026-10-14S4

Wk 3 · Vol 1.54x

2026-10-13S4

Wk 3 · Vol 2.35x

2026-10-12S4

Wk 3 · Vol 2.33x

2026-10-09S4

Wk 2 · Vol 3.21x

2026-10-08S4

Wk 2 · Vol 0.94x

2026-10-07S4

Wk 2 · Vol 1.91x

Moving averages & range

50 DMA

$0.89

200 DMA

$1.00

52W High

$1.70

52W Low

$0.29

5D Low

$0.65

Resistance levels (recent highs)

20d High

$0.92

60d High

$1.09

120d High

$1.47

250d High

$1.70

Next resistance

+35.3%

to 20d High

ROE

-361.4%

Profit margin -82.9%

Dividend Yield

0.00%

P/B -3.1

XWELL: quick answers

What stage is XWELL in?

As of Oct 22, 2026, XWELL (XWEL) is in Stage 4, the downtrend phase. It entered Stage 4 on Sep 28, 2026 and is in week 4. What the four stages mean

Is XWELL in an uptrend?

No. XWELL is in a Stage 4 downtrend. It trades 31.8% below its 200-day average, which is rising.

How far is XWELL from its 52-week high?

XWELL closed at $0.68 on Oct 22, 2026, 60.0% below its 52-week high of $1.70. Its 52-week low is $0.29.

How has XWELL performed over the past year?

As of Oct 22, 2026, XWELL is down 30.6% over the past year and up 51.1% so far in 2026.

Which sector and industry is XWELL in?

XWELL is in the Diagnostics & Research industry, part of the Health Care sector.

About this companyHealth Care· Diagnostics & Research

XWELL, Inc. engages in the provision of health and wellness services to travelers in the United States and internationally. It operates in three segments: XpresSpa, XpresTest, and Naples Wax Center. The XpresSpa segment provides traveler's spa services, including massage, and nail and skin care services, as well as spa and travel products. The XpresTest segment offers COVID-19 and other medical testing to the traveling public, as well as airline, airport and concessionaire employees, and TSA and U.S. customs and border protection agents; aircraft wastewater and passenger nasal sampling through the CDC's bio-surveillance program; and various services and support, including technical support services and advanced services. The Napple Wax Center segment offers skincare and cometic products, as well as face and body waxing services. It offers its services through stores and kiosks, as well as online. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022. XWELL, Inc. is based in New York, New York.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.